James L. Gulley

Resources Required for Semi-Automatic Volumetric Measurements in Metastatic Chordoma: Is Potentially Improved Tumor Burden Assessment Worth the Time Burden?

Kathleen E. Fenerty, Nicholas J. Patronas, Christopher R. Heery, 2016, Journal of Digital Imaging.

Deep Learning Based Staging of Bone Lesions From Computed Tomography Scans

Nathan Lay, Ulas Bagci, Baris Turkbey, 2021, IEEE Access.

A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells

James L. Gulley, J. Schlom, J. Gulley, 2017, Oncoimmunology.

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy

James L. Gulley, Ira Pastan, I. Pastan, 2009, Cancer Immunology, Immunotherapy.

Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease

Colin C. Pritchard, James L. Gulley, John M. Kirkwood, 2018, Journal of Immunotherapy for Cancer.

Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trial

Walter M. Stadler, Christopher R. Heery, James L. Gulley, 2016, Oncotarget.

Augmented Radiologist Workflow Improves Report Value and Saves Time: A Potential Model for Implementation of Artificial Intelligence.

Baris Turkbey, James L. Gulley, Les R. Folio, 2020, Academic radiology.

Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types

Christopher R. Heery, James L. Gulley, Jacob Richards, 2016, Journal of circulating biomarkers.